BURLINGAME, Calif., May 22, 2024
/PRNewswire/ -- The global Non Opioid Pain Treatment
Market is projected to grow from USD
78.89 billion in 2024, and it is projected to reach
USD 140.56 billion by 2031, at a CAGR
of 8.6% from 2024 to 2031, as per the recent study by Coherent
Market Insights. The global non-opioid pain treatment market is
expected to witness significant growth over the forecast period
owing to growing preference for non-addictive pain management
therapies and risk of opioid addiction and overdose.
Get Sample Pages:
https://www.coherentmarketinsights.com/insight/request-sample/6741
The growth of the global non-opioid pain treatment market is
majorly driven by the increasing preference for non-addictive
alternatives to opioid painkillers and growing awareness about the
risks and side effects associated with opioid medications.
Additionally, favorable government initiatives and reimbursement
policies for non-opioid therapies are also contributing to the
market growth. However, high costs associated with branded
non-opioid medications may hinder the market growth.
Global Non Opioid Pain Treatment Market Report
Coverage
Report
Coverage
|
Details
|
Market Revenue in
2024
|
$78.89 billion
|
Estimated Value by
2031
|
$140.56 billion
|
Growth
Rate
|
Poised to grow at a
CAGR of 8.6%
|
Historical
Data
|
2019–2023
|
Forecast
Period
|
2024–2031
|
Forecast
Units
|
Value (USD
Million/Billion)
|
Report
Coverage
|
Revenue Forecast,
Competitive Landscape, Growth Factors, and Trends
|
Segments
Covered
|
By Drug Type, By
Indication, By Route of Administration, By Distribution
Channel
|
Geographies
Covered
|
North America, Europe,
Asia Pacific, and Rest of World
|
Growth
Drivers
|
• Rising prevalence of
chronic conditions
• Increased awareness
about opioid epidemic
|
Restraints &
Challenges
|
• Side effects of
existing drugs
• Lack of reimbursement
policies
|
Nutraceuticals are emerging as a popular non-opioid treatment
option for pain management. Products containing ingredients like
turmeric, ginger, omega-3 fatty acids, and other herbs that have
anti-inflammatory and pain-relieving properties are gaining
prominence. Likewise, cannabidiol (CBD) products are witnessing
high demand for therapeutic uses including pain management.
However, CBD remains controversial as a medicine due to legal
restrictions in many countries. Another major trend is the adoption
of non-drug therapies like acupuncture, massage, transcutaneous
electrical nerve stimulation, and spinal manipulation for pain
relief with lesser side effects. These complementary and
alternative therapies are preferred along with medications to
manage chronic pain holistically without relying only on drugs.
The non-steroidal anti-inflammatory drugs segment is expected to
hold the dominant position in the drug type segment during the
forecast period. NSAIDs are widely used for the treatment of pain
as they provide relief from pain and inflammation. NSAIDs work by
blocking the production of prostaglandins, which are chemicals in
the body that promote pain and inflammation. Some common NSAIDs
include ibuprofen, naproxen and diclofenac.
The musculoskeletal disorder segment is anticipated to be the
most lucrative segment by indication during the forecast period.
Musculoskeletal disorders are common conditions that affect the
human body's movement or musculoskeletal system such as muscles,
tendons, ligaments, nerves, discs and blood vessels. Conditions
such as back pain, arthritis and injuries are primary causes of
musculoskeletal disorders. Non-opioid treatments are widely used to
manage pain associated with musculoskeletal disorders.
Get 10% Customization on this Report:
https://www.coherentmarketinsights.com/insight/request-customization/6741
The tropical route of administration segment is expected to
dominate the market by route of administration owing to low cost
and easy self-administration of tropical formulations. In this
route, drugs are applied to the skin and hair for local or systemic
effects. Some commonly used forms include ointments, lotions,
creams, gels and patches. The absorption of drugs is relatively
fast through the skin and provides direct sensation of pain
relief.
The online pharmacies distribution channel segment is projected
to witness significant growth over the forecast period owing to the
convenience of online platforms for purchase of medications without
visiting a pharmacy physically. Online pharmacies provide a wide
range of pain medication options with detailed information. They
also offer attractive deals and discounts. Increased internet
penetration and preference of e-commerce among younger population
will support the growth of this segment.
Recent Developments:
In February 2024, Hukma
Pharmaceutical PLC declared that COMBOGESIC IV injection would be
available in the U.S.
In December 2023, in a mid-stage
experiment Vertex Pharmaceutical reported that a non-opioid
painkiller effectively reduce pain in diabetic patient with chronic
nerve pain, igniting efforts to create a drug without the risk of
addiction.
Key Market Takeaways:
The global non-opioid pain treatment market is anticipated to
witness a CAGR of 8.6% during the forecast period 2024-2031, owing
to the growing geriatric population which is more prone to pain
conditions like arthritis, and rising awareness about risks
associated with opioids.
On the basis of drug type, non-steroidal anti-inflammatory drugs
segment is expected to hold a dominant position, owing to
widespread usage of inexpensive NSAIDs like ibuprofen. By
indication, musculoskeletal disorder segment will dominate due to
high prevalence of conditions like back pain.
Regionally, North America is
expected to hold the dominant position over the forecast period due
to growing adoption of non-opioid therapies encouraged by
regulatory policies.
Key players operating in the market include Pfizer Inc., Teva
Pharmaceutical Industries Ltd, Dr. Reddy's Laboratories Ltd., Sun
Pharmaceutical Industries Ltd., and Cipla Inc. among others. These
players are involved in various strategic collaborations and new
product launches to strengthen their market position.
Immediate Delivery Available | Buy This Premium Research
Report:
https://www.coherentmarketinsights.com/insight/buy-now/6741
Browse More Insights:
- Tobramycin Eye Drop Market: Global tobramycin eye drop
market is estimated to be valued at USD
1,018.9 Mn in 2024 and is expected to reach USD 2,573.2 Mn by 2031, exhibiting a compound
annual growth rate (CAGR) of 14.1% from 2024 to 2031.
- Joint Pain Injections Market: The global
joint pain injections market is estimated to be valued at USD
5.29 Bn in 2024 and is expected to reach USD
9.46 Bn by 2031, exhibiting a compound annual growth
rate (CAGR) of 8.7% from 2024 to 2031.
- Medical Composites Market: The global
medical composites market is estimated to be valued at USD
1.23 Bn in 2024 and is expected to reach USD
2.36 Bn by 2031, exhibiting a compound annual growth
rate (CAGR) of 9.8% from 2024 to 2031.
- Temperature Controlled Pharmaceutical Containers Market:
Global temperature controlled pharmaceutical
containers market is estimated to be valued at USD
5.09 Bn in 2024 and is expected to reach USD
10.26 Bn by 2031, exhibiting a compound annual growth
rate (CAGR) of 10.5% from 2024 to 2031.
- Throat Lozenges Market: Global throat
lozenges market is estimated to be valued at USD 4.59
Bn in 2024 and is expected to reach USD 6.80 Bn
by 2031, exhibiting a compound annual growth rate
(CAGR) of 5.8% from 2024 to 2031.
About Us:
Coherent Market Insights is a global market intelligence and
consulting organization that provides syndicated research reports,
customized research reports, and consulting services. We are known
for our actionable insights and authentic reports in various
domains including aerospace and defense, agriculture, food and
beverages, automotive, chemicals and materials, and virtually all
domains and an exhaustive list of sub-domains under the sun. We
create value for clients through our highly reliable and accurate
reports. We are also committed in playing a leading role in
offering insights in various sectors post-COVID-19 and continue to
deliver measurable, sustainable results for our clients.
Contact Us:
Mr. Shah
Senior Client Partner – Business Development
Coherent Market Insights
Phone:
US: +1-206-701-6702
UK: +44-020-8133-4027
Japan: +81-050-5539-1737
India: +91-848-285-0837
Email: sales@coherentmarketinsights.com
Website: https://www.coherentmarketinsights.com
Follow Us: LinkedIn | Twitter
Logo -
https://mma.prnewswire.com/media/902389/Coherent_Market_Insights_Logo.jpg
View original
content:https://www.prnewswire.com/news-releases/global-non-opioid-pain-treatment-market-size-to-worth-usd-140-56-bn-by-2031--302152631.html
SOURCE Coherent Market Insights